J. David Enloe, Jr
Overview
J. David Enloe, Jr received an average of $1M in total compensation, including $378K in salary, at Recro Pharma from 2020 to 2022.
Source: SEC filings on April 6, 2023, April 1, 2022, and March 25, 2021.
Related executives
We found eight more executives who work or worked at Recro Pharma.
Ryan Lake
Recro Pharma
Chief Financial Officer
Gerri Henwood
Recro Pharma
Chief Executive Officer
Michael Celano
Recro Pharma
Chief Operating Officer
Ryan Lake
Recro Pharma
Chief Financial Officer
Stewart McCallum
Recro Pharma
Chief Medical Officer
Fred Graff
Recro Pharma
Chief Commercial Officer
Randall Mack
Recro Pharma
Senior Vice President, Development
Charles Garner
Recro Pharma